These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 8902548)
1. 5-HTP induced diarrhea as a carcinoid syndrome model in mice? Bourin M; Hascoet M; Deguiral P Fundam Clin Pharmacol; 1996; 10(5):450-7. PubMed ID: 8902548 [TBL] [Abstract][Full Text] [Related]
2. The involvement of 5-HT3 and 5-HT4 receptors in two models of gastrointestinal transit in mice. Pascual D; Alsasua A; Goicoechea C; Martín MI Neurosci Lett; 2002 Jul; 326(3):163-6. PubMed ID: 12095647 [TBL] [Abstract][Full Text] [Related]
3. Actions of 5-hydroxytryptophan to inhibit and disinhibit mouse behaviour in the light/dark test. Cheng CH; Costall B; Kelly ME; Naylor RJ Eur J Pharmacol; 1994 Apr; 255(1-3):39-49. PubMed ID: 7913044 [TBL] [Abstract][Full Text] [Related]
4. Evidence for the involvement of 5-hydroxytryptamine 4 receptors in 5-hydroxytryptophan-induced diarrhea in mice. Hedge SS; Moy TM; Perry MR; Loeb M; Eglen RM J Pharmacol Exp Ther; 1994 Nov; 271(2):741-7. PubMed ID: 7965791 [TBL] [Abstract][Full Text] [Related]
5. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis. Darmani NA; Johnson JC Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052 [TBL] [Abstract][Full Text] [Related]
6. Increased defecation during stress or after 5-hydroxytryptophan: selective inhibition by the 5-HT(4) receptor antagonist, SB-207266. Sanger GJ; Yoshida M; Yahyah M; Kitazumi K Br J Pharmacol; 2000 Jun; 130(3):706-12. PubMed ID: 10821802 [TBL] [Abstract][Full Text] [Related]
7. 5-Hydroxytryptamine affects rat migrating myoelectric complexes through different receptor subtypes: evidence from 5-hydroxytryptophan administration. Sagrada A; Brancaccio N; Schiavone A Life Sci; 1990; 46(17):1207-16. PubMed ID: 2338886 [TBL] [Abstract][Full Text] [Related]
9. Involvement of 5-HT1, 5-HT2, and 5-HT3 receptors in the mediation of the prolactin response to serotonin and 5-hydroxytryptophan. Jørgensen H; Knigge U; Warberg J Neuroendocrinology; 1992 Mar; 55(3):336-43. PubMed ID: 1386914 [TBL] [Abstract][Full Text] [Related]
10. New benzimidazole derivatives: selective and orally active 5-HT3 receptor antagonists. Pascual D; Girón R; Alsasua A; Benhamú B; López-Rodríguez ML; Martín MI Eur J Pharmacol; 2003 Feb; 462(1-3):99-107. PubMed ID: 12591101 [TBL] [Abstract][Full Text] [Related]
11. 5-HT3 receptor antagonists. 3. Quinoline derivatives which may be effective in the therapy of irritable bowel syndrome. Kishibayashi N; Miwa Y; Hayashi H; Ishii A; Ichikawa S; Nonaka H; Yokoyama T; Suzuki F J Med Chem; 1993 Oct; 36(22):3286-92. PubMed ID: 8230119 [TBL] [Abstract][Full Text] [Related]
12. Different serotonin receptor types participate in 5-hydroxytryptophan-induced gonadotropins and prolactin release in the female infantile rat. Lacau-Mengido IM; Libertun C; Becú-Villalobos D Neuroendocrinology; 1996 May; 63(5):415-21. PubMed ID: 8738578 [TBL] [Abstract][Full Text] [Related]
13. Serum leptin levels after central and systemic injection of a serotonin precursor, 5-hydroxytryptophan, in mice. Yamada J; Ujikawa M; Sugimoto Y Eur J Pharmacol; 2000 Oct; 406(1):159-62. PubMed ID: 11011048 [TBL] [Abstract][Full Text] [Related]
14. 5-HT receptor subtypes involved in the serotonin-induced inhibition of L-leucine absorption in rabbit jejunum. Salvador MT; Rodríguez-Yoldi MC; Alcalde AI; Rodríguez-Yoldi MJ Life Sci; 1997; 61(3):309-18. PubMed ID: 9217291 [TBL] [Abstract][Full Text] [Related]
15. Modulation by 5-HT3 and 5-HT4 receptors of the release of 5-hydroxytryptamine from the guinea-pig small intestine. Gebauer A; Merger M; Kilbinger H Naunyn Schmiedebergs Arch Pharmacol; 1993 Feb; 347(2):137-40. PubMed ID: 8474534 [TBL] [Abstract][Full Text] [Related]
16. The pharmacology of the 5-HT4 receptor. Costall B; Naylor RJ Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():11-8. PubMed ID: 8201242 [TBL] [Abstract][Full Text] [Related]
17. Use of stereoisomers of zacopride to analyze actions of 5-hydroxytryptamine on enteric neurons. Wade PR; Mawe GM; Branchek TA; Gershon MD Am J Physiol; 1991 Jan; 260(1 Pt 1):G80-90. PubMed ID: 1987811 [TBL] [Abstract][Full Text] [Related]
18. Effect of FK1052, a potent 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptor dual antagonist, on colonic function in vivo. Kadowaki M; Nagakura Y; Tomoi M; Mori J; Kohsaka M J Pharmacol Exp Ther; 1993 Jul; 266(1):74-80. PubMed ID: 8331576 [TBL] [Abstract][Full Text] [Related]
19. Increased defaecation caused by 5-HT4 receptor activation in the mouse. Banner SE; Smith MI; Bywater D; Gaster LM; Sanger GJ Eur J Pharmacol; 1996 Jul; 308(2):181-6. PubMed ID: 8840130 [TBL] [Abstract][Full Text] [Related]
20. Further characterization, by use of tryptamine and benzamide derivatives, of the putative 5-HT4 receptor mediating tachycardia in the pig. Villalón CM; den Boer MO; Heiligers JP; Saxena PR Br J Pharmacol; 1991 Jan; 102(1):107-12. PubMed ID: 2043916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]